Fertility Test Market Size

  • Report ID: 3231
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Fertility Test Market Size

Fertility Test Market size was valued at USD 588.81 million in 2024 and is poised to exceed USD 1.67 billion by the end of 2037, expanding at over 8.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of fertility test is evaluated at USD 628.38 million.. The market growth is primarily being attributed to the growing prevalence of polycystic ovarian syndrome among female population. Between 4% and 20% of people worldwide are believed to have PCOS. According to estimates from the World Health Organization (WHO), PCOS affects about 116 million women worldwide (3.4%).

Besides this, the rise in the number of people suffering with infertility is expected to boost the growth of the fertility test market. There are many factors that contribute to infertility, including low sperm count and limited sperm motility in men and failure to ovulate, damaged cervixes and fallopian tubes in women. The World Health Organization (WHO) statistics show that 186 million people worldwide, including 45 million couples, are infertile. Furthermore, the integration of technology in fertility test is also anticipated to augment the market growth. For instance, the development of artificial intelligence in IVF could be advantageous to the entire process. According to the National Library of Medicine, AI can recognize human sperm with an accuracy of 89.9% and properly forecast whether a live delivery will occur.


Fertility Test Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3231
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of fertility test is evaluated at USD 628.38 million.

The fertility test market size was valued at USD 588.81 million in 2024 and is poised to exceed USD 1.67 billion by the end of 2037, expanding at over 8.3% CAGR during the forecast period i.e., between 2025-2037. Rising instances of infertility in both males and females, rising pervasion of PCOD, and rise in the average age of first time motherhood will boost the market growth.

North America industry is expected to hold largest revenue share by 2037, driven by rise in the cases of infertility in the region.

The major players in the market include Swiss Precision Diagnostics, Legacy, Inc., Dadi Inc., Everlywell, Inc., Fertility Focus, ExSeed Health, Geratherm Medical, VirtualExpo, AdvaCare Pharma, Valley Electronics AG.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample